AMP 2026 has ended. This guide stays up as the record of who was there. Next: AMP 2027, Nov 9–13, 2027 in Baltimore

Cellecta at AMP 2026

Nov 10–14, 2026 Seattle, WA ~2k attendees Website

Cellecta brings 2 presentations to AMP 2026 in Seattle, and exhibits at Booth 2205. Its sessions cover workflows for mapping antigen-specific T-cell and B-cell clonotypes, and how those clonotypes feed receptor-based target and biomarker discovery. The company supplies genomic products and services including viral vectors, functional screening and multiplex qRT-PCR.

OrganizationAMP 2026 Attendance
Cellecta
Mountain View, CA
Suppliers
Genomic products and services for drug target and biomarker discovery: viral vector production, functional screening, cell engineering and multiplex qRT-PCR.
Booth
Exhibiting at Booth 2205
Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm
Workshop
Wed, Nov 11
2:00pm–2:50pm
From Repertoire to Response: A Workflow for Mapping Antigen-Specific T- and B-Cell Clonotypes for Receptor-Based Target Discovery
Pairing immune receptor sequencing with antigen screening to rank tumour-specific T- and B-cell clonotypes, including from plasma.
Workshop
Sat, Nov 14
9:30am–10:00am
Discovery and Validation of T- and B-Cell Clonotypes to Drive Next-Level Drug and Biomarker Discovery
An end-to-end route from bulk and single-cell receptor sequencing to screening that surfaces drug and biomarker candidates.

Explore the full AMP 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Seattle. Leave your work email and we’ll be in touch.

Privacy

Download the full AMP 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Cellecta

Tell us what you sell and we’ll find the people at Cellecta most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction